What Happened
A Baltimore pharmacist and his pharmacy paid $15,000 and accepted new dispensing controls under a federal consent decree after the government alleged they filled fraudulent controlled-substance prescriptions while ignoring obvious red flags.
Ketan K. Dankhara owned and worked as the pharmacist at Falls RX, LLC d/b/a Ultra Care Pharmacy Baltimore. The government alleged that shortly after the pharmacy opened, an individual repeatedly brought in controlled-substance prescriptions for a number of different people at the same time, many of whom had never previously visited the pharmacy. Several of the prescriptions were for the same drug, strength, and quantity, written by the same prescriber; some were written by an OB/GYN for patients who were biologically male. Dankhara made no attempt to resolve these red flags, and on at least one prescription he indicated he had spoken with the prescriber to verify it when, in fact, he later admitted he had not.
A federal judge approved a consent decree in which Dankhara and Ultra Care neither admitted nor denied liability but agreed to pay a $15,000 civil monetary penalty and to implement specific documented procedures for identifying and resolving red flags — including cross-gender OB/GYN prescriptions and prescriptions presented in bulk for unrelated patients — before filling them going forward.
What Went Wrong
- Textbook red flags went unresolved. Identical drug, strength, and quantity across multiple unrelated patients from the same prescriber is one of the most basic diversion indicators, and it was filled anyway.
- Prescriber specialty didn't match the drug. An OB/GYN prescribing controlled substances to biologically male patients is inconsistent with the prescriber's practice area — a mismatch the pharmacy did not investigate.
- Verification was falsified rather than skipped. Documenting a prescriber phone call that never happened converts a missed check into an affirmative misrepresentation.
- One person presenting prescriptions for a group of first-time, unrelated patients simultaneously is a classic straw-patient pattern that wasn't escalated.
How It Could Have Been Prevented
- Require pharmacists to document genuine, verifiable contact with prescribers before filling flagged prescriptions, with spot-checks against prescriber phone records.
- Flag prescriptions where the prescriber's specialty doesn't plausibly match the drug or the patient's apparent demographics for mandatory pharmacist-in-charge review.
- Train staff to treat one person presenting multiple patients' prescriptions simultaneously as an automatic corresponding-responsibility red flag requiring individualized verification of each patient.
- Build a periodic internal audit of prescriptions sharing identical drug/strength/quantity/prescriber combinations across different patients.
Related Guidance
- 15 Red Flags of Drug Diversion — Prescription-pattern and corresponding-responsibility red flags for dispensing pharmacists.
- Regulatory Guide — DEA corresponding-responsibility obligations under the Controlled Substances Act.
- Community Pharmacy Self-Assessment Checklist — Self-assessment covering red-flag identification and documentation.
- More Diversion Case Studies — Additional pharmacy-level enforcement actions.